Enterprise Value

-359.8K

Cash

7.571M

Avg Qtr Burn

-5.311M

Short % of Float

1.79%

Insider Ownership

20.77%

Institutional Own.

41.34%

Qtr Updated

12/31/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Zagociguat (CY6463) Details
Neurological disorder, Alzheimer's disease, Dementia

Phase 2

Update

Zagociguat (CY6463) Details
Cognitive Impairment Associated with Schizophrenia

Phase 1b

Update

Failed

Discontinued

Olinciguat Details
Sickle cell disease

Failed

Discontinued

Zagociguat (CY6463) Details
Rare diseases, Mitochondrial disease, Rare genetic disease

Failed

Discontinued